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INTRODUCTION 
Keratoconus is a non inflammatory progressive corneal thinning of unknown etiology 
in which the cornea assumes a conical shape, resulting in mild to marked impairment 
of visual acuity due to irregular astigmatism, progressive myopia and central corneal 
scarring. A reduced number of collagen cross-links and a pepsin digestion higher than 
normal induce an overall structural weakness of the corneal tissue, resulting in a 
stiffness that is only 60% of normal cornea. Changes in corneal collagen structure, 
organization and intercellular matrix as well as apoptosis and necrosis of 
keratinocytes, prevalently or exclusively involving the central anterior stroma and 
Bowman’s lamina are documented in literature. Corneal collagen cross-linking (C3R) 
is a new approach to increase the mechanical and biochemical strength of corneal 
tissue. 
 
BASIC PRINCIPLE-The aim of this treatment is to create additional chemical bonds 
inside the corneal stroma by means of highly localised photopolymerisation while 
minimising exposure to surrounding ocular structures. 
  Using UVA at 370nm and the photosensitizer riboflavin, the photosensitizer is 
excited into its triplet state generating the reactive oxygen species (ROS). These are 
mainly in the form of singlet oxygen and to a much less degree, they may be in the 
form of superoxide anion radicals. The ROS then reacts with various molecules, 
including chemical covalent bonds, bridging amino groups of collagen fibrils(type 2 
photochemical reaction).The wavelength of 370nm was chosen because of an 
absorption peak of riboflavin at this wavelength. 
 
AIMS AND OBJECTIVES 
-To evaluate the safety of C3R as measured by intra operative and postoperative 
complications   
-To measure the efficacy of C3R in bringing progressive keratoconus to a halt  
 
MATERIALS AND METHODS 
TYPE OF STUDY 
Prospective interventional clinical trial  
CASE COLLECTION PERIOD - 1 year 
FOLLOW UP PERIOD - 1 year 
SAMPLE SIZE - 50 patients 
 
SELECTION CRITERIA 
Inclusion criteria 
Progressive keratoconus 
Age between 12 to 30 years 
Corneal pachymetry> 400 microns at thinnest point 
Normal corneal endothelium 
Maximum corneal curvature < 60 D 
Willing for follow up 
Exclusion criteria 
Corneal thickness < 400 microns at thinnest point 
H/O herpetic keratitis  
Central or paracentral opacities 
Prior corneal surgery 
Severe  dry eye and ocular surface disorders 
Concurrent corneal infections 
Concomitant autoimmune diseases 
Pregnant/nursing women 
Hormone therapy 
 
EVALUATION PARAMETERS 
· UDVA 
· CDVA 
· CLVA 
· Refraction 
· Slit lamp biomicroscopy 
· Fundus evaluation 
· Non contact tonometry 
· Tear Film break up time 
· OrbscanIIz (Bausch & Lomb) 
· Specular microscopy (Topcon SP 3000 P) 
· Clinical Photograph (Haag Streit) 
 
SAFETY PARAMETERS 
Post operative complications: - 
• Non healing/Persistent Epithelial Defect  
       (a) <2mm (b) 2-5 mm (c ) >5 mm 
• Permanent stromal Haze 
       (a) mild  (b) moderate (c)  severe 
• Corneal Scarring  
      (a) nebular (b) macular (c) leucomatous 
• Infective keratitis 
• Corneal melting 
• Corneal Infiltrate- 
       1. Number  (a) single  (b) multiple               
       2. Size  (a) <2mm  (b) 2-5 mm  (c )>5 mm    
       3. Type    (a) bacterial   (b) fungal   (c ) sterile   
• Endothelial cell loss 
• Cataract formation 
• Retinal pathology 
• Loss of 2 or more lines in BCVA 
EFFICACY PARAMETERS 
· Best corrected distance visual acuity-  
1. Spectacle corrected 
2. Contact lens corrected 
· Refraction- 
1.  Spherical 
2.  Cylindrical with axis 
3.  Mean spherical equivalent 
· ORBSCAN IIz 
1. Sim K     
2. K max      
3. Thinnest pachymetry 
4. Anterior float BFS difference   
5. Posterior float BFS difference   
6. 3mm zone irregularities   
7.  5mm zone irregularities 
 
METHODOLOGY 
-All patients with documented progression of keratoconus(more than 0.5 diopter 
increase in the past 1 year) were included. 
-Preoperative measurements included uncorrected visual acuity,best corrected and 
contact lens visual acuity,refraction, intra ocular tension (Non contact tonometry), 
keratometry, specular microscopy and ORBSCAN IIzreadings. 
-The eye with advanced keratoconus was treated with C3R while the other eye served 
as the control. 
-The patients were called for follow-up at 1 week,1 month,3 months,6 months and 12 
months postoperatively. All necessary investigations were done at each visit. 
-The progression of keratoconus (if any) was documented and was compared with the 
fellow control eye. 
-Intraoperative and postoperative complications (if any) were documented. 
 
 
RESULTS 
DEMOGRAPHICS 
The mean age of presentation was 17.72 years (SD= 2.98) with a range of 12 to 26 
years. A total of 50 patients were enrolled in the study, with 31 males (62%) and 19 
females (38%) 
 
VISUAL ACUITY 
In our study,we found a significant improvement in uncorrected visual acuity 
(UDVA) at 12 months follow up visit by 0.11 log MAR units which was significant 
with respect to the controls where no significant change was observed. 
    In the corrected distance visual acuity, no significant improvement was observed at 
6 months and 12 months in both the case and the control group.  
REFRACTION 
In our study, a mean decrease in refractive cylinder by 0.44D was observed at 6 
months and 0.50D at 1 year, which however was not significant with respect to the 
control group. The spherical equivalent showed no significant change in the cases but 
a significant increase in the control group at 6 months and 12 months. There was no 
significant change in refractive sphere in either group 
ORBSCAN IIz 
There was a significant reduction in simulated keratometry, maximum keratometry, 
anterior float, posterior float, 3mm and 5 mm zone irregularities in the cases with 
respect to preoperative values and values at 6 months and 12 months. The thinnest 
pachymetry underwent significant reduction from one-month postoperative followup. 
 
COMPLICATIONS 
There was no significant change the intraocular pressure at follow up visits in either 
group. We also observed transient stromal haze in a majority of our patients, which 
persisted beyond 3 months in 30 patients (60%). Mild scarring was seen in 13(26%) 
of our patients. No cases of keratitis, infiltrate or corneal melting were seen.We 
observed no lens changes or induced retinal pathologies in our study. 
CONCLUSION 
Collagen crosslinking is a safe and effective procedure to halt the progression of 
disease in cases of mild to moderate keratoconus. 
 
 
 
 
